Piershale Financial Group’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Piershale Financial Group's RGEN Position: Q1 2023 in Review
Piershale Financial Group sold out of Repligen (RGEN) in Q1 2023, closing a stake of 55 shares — an estimated $9.31K sold.
Piershale Financial Group first reported a position in RGEN in Q4 2022 and held it in 1 quarter. The position peaked at $9.31K in Q4 2022. 447 funds tracked by Wall St. Rank hold RGEN as of Q1 2023.
- Piershale Financial Group reported no remaining Repligen position as of Q1 2023 after selling out during the quarter.
- Piershale Financial Group sold 55 Repligen shares in Q1 2023, an estimated $9.31K.
- Piershale Financial Group first reported a position in Repligen in Q4 2022 and held it in 1 quarter.
- Piershale Financial Group's Repligen position peaked at $9.31K in Q4 2022.
- 447 funds tracked by Wall St. Rank held Repligen as of Q1 2023.
Based on Piershale Financial Group's 13F filing for Q1 2023, filed 12 Apr 2023.